doi: 10.1021/acs.jmedchem.5b00726 61 Eli Lilly and Company
The drug protects the heart in people without diabetes, and in people whose blood sugar does not move
Good candidates typically have a BMI over 30, or a BMI of 27 or higher along with one or more weight-related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol
In a double-blind, placebo-controlled study, overweight participants taking 400mg of Morosil daily the exact dose in Lemme GLP-1 Daily showed significant reductions in body weight, BMI, and waist circumference over 12 weeks
Discover a smarter way to support your body and mind no pills, no powders, just simple transdermal wellness
New York Citys health insurer stopped covering GLP-1 drugs for city employees in 2025 while Bostons leaders are considering limiting such coverage for city employees because of an insurance rate hike largely driven by the GLP-1 drug cost